Skip to content

Mescaline: all studies

Page 43 of 97: studies 421 to 430 of 965, newest first. Back to the mescaline overview

Research

Hallucinogenic Drugs

Encyclopedia of Life Sciences August 15, 2012 Katherine R. Bonson 5 citations

Abstract Hallucinogens constitute one of the oldest classes of drugs used by humanity, often in the context of spiritual practices. Classic hallucinogens such as lysergic acid diethylamide (LSD), psilocybin, N,N ‐dimethyltryptamine (DMT), mescaline and 2,5‐dimethoxy‐4‐methylamphetamine (DOM) produce complex psychological and physical effects, including perceptual changes, cognitive shifts in...

A Comparative Review of the Neuro-Psychopharmacology of Hallucinogen-Induced Altered States of Consciousness: The Uniqueness of Some Hallucinogens

NeuroQuantology June 1, 2012 Ümit Sayın 17 citations

Altered states of consciousness induced by hallucinogens (H-ASC) is still a vaguely understood phenomenon. Taken the diverse psychological effects they exert, the main mechanism of action of hallucinogens; LSD, ibogaine, THC, PCP, MDMA, methamphetamine, mescaline, psilocybin and DMT, of which psychological effects are discussed in the article, are not properly understood and explained by the...

Substance use initiation: The role of simultaneous polysubstance use

Drug and Alcohol Review May 21, 2012 Janine V. Olthuis, Christine Darredeau, Sean P. Barrett 79 citations

Abstract Introduction and Aims. Simultaneous polysubstance use (SPU) is a common phenomenon, yet little is known about its role in substance use initiation. Design and Methods. In the present study, 226 cannabis users completed structured interviews about their substance use history. For each substance ever used, participants provided details of their age of first use, their use in the...

Fluorine in psychedelic phenethylamines

Drug Testing and Analysis February 28, 2012 Daniel Trachsel 32 citations

The so‐called psychedelic phenethylamines represent a class of drugs with a large range of psychoactive properties in humans, ranging from naturally occurring mescaline to amphetamine analogues and homologues. The interest in many of these compounds, occasionally referred to as designer‐drugs, is widely dispersed across popular culture and political and scientific communities. In recent...

DOI: 10.1002/dta.413 (opens in new tab) Mescaline Phenethylamines Designer drug Pharmacology +3

Voice of the Psychonauts: Coping, Life Purpose, and Spirituality in Psychedelic Drug Users

Journal of Psychoactive Drugs July 1, 2011 Levente Móró, Katalin Simon, Imre Bárd et al. 138 citations

Psychoactive drug use shows great diversity, but due to a disproportionate focus on problematic drug use, predominant nonproblematic drug use remains an understudied phenomenon. Historic and anecdotal evidence shows that natural sources of "psychedelic" drugs (e.g., mescaline and psilocybin) have been used in religious and spiritual settings for centuries, as well as for psychological...

1-[(1-Methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 Positive Allosteric Modulators for the Treatment of Psychosis

Journal of Medicinal Chemistry March 2, 2011 Lei Zhang, Michael A. Brodney, John Candler et al. 32 citations

A novel series of mGluR2 positive allosteric modulators (PAMs), 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines, is herein disclosed. Structure-activity relationship studies led to potent, selective mGluR2 PAMs with excellent pharmacokinetic profiles. A representative lead compound (+)-17e demonstrated dose-dependent inhibition of methamphetamine-induced hyperactivity and...

DOI: 10.1021/jm101414h (opens in new tab) Mescaline Allosteric regulation Methamphetamine Pharmacology +3

A new classification of the psychoactive substances (stimulants, entactogens, hallucinogens)

Pharmacopsychiatry August 31, 2009 Torsten Passie

The classification of psychoactive substances (stimulants, entactogens, hallucinogens) in the frame of psychopharmacology was not worked on since the 1960s. Based on the authors empirical and theoretical research about the psychophysical correlates of waking altered states of consciousness, he lecture will present a recently developed new classification of psychoactive substances. Method: The...

From trans-methylation to cytosine methylation: Evolution of the methylation hypothesis of schizophrenia

Epigenetics April 30, 2009 Dennis R. Grayson, Ying Chen, Erbo Dong et al. 54 citations

The role of methylation in the history of psychiatry has traversed a storied path. The original trans-methylation hypothesis was proposed at a time when chlorpromazine had been synthesized but not yet marketed as an antipsychotic (Thorazine). The premise was that abnormal metabolism led to the methylation of biogenic amines in the brains of schizophrenia patients and that these hallucinogenic...

DOI: 10.4161/epi.4.3.8534 (opens in new tab) Mescaline Epigenetics Dna methylation Psychosis +1

Agonist-Trafficking and Hallucinogens

Current Medicinal Chemistry March 1, 2009 Javier González-Maeso, Stuart C. Sealfon 74 citations

Seven transmembrane domain receptors, also termed G protein-coupled receptors (GPCRs), represent the most common molecular target for therapeutic drugs. The generally accepted pharmacological model for GPCR activation is the ternary complex model, in which GPCRs exist in a dynamic equilibrium between the active and inactive conformational states. However, the demonstration that different...

Diagnosis and distress in Navajo healing.

The Journal of Nervous and Mental Disease August 1, 2008 Thomas J Csordas, Michael J Storck, Milton Strauss

In contemporary Navajo society, traditional Navajo ceremonies, Native American Church prayer meetings, and Navajo Christian faith healing are all highly sought-after resources in the everyday pursuit of health and well-being. What is the nature of affliction among patients who turn to such forms of religious healing? Are these patients typically afflicted with psychiatric disorder? In this...